+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bupivacaine Liposome Injection Market by End Use (Ambulatory Surgery Centers, Clinics, Hospitals), Indication (Postoperative Pain Management, Regional Anesthesia), Application, Distribution Channel, Patient Type, Product Type, Packaging - Global Forecast 2025-2030- Product Image
Bupivacaine Liposome Injection Market by End Use (Ambulatory Surgery Centers, Clinics, Hospitals), Indication (Postoperative Pain Management, Regional Anesthesia), Application, Distribution Channel, Patient Type, Product Type, Packaging - Global Forecast 2025-2030- Product Image
Sale

Bupivacaine Liposome Injection Market by End Use (Ambulatory Surgery Centers, Clinics, Hospitals), Indication (Postoperative Pain Management, Regional Anesthesia), Application, Distribution Channel, Patient Type, Product Type, Packaging - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6084550
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Bupivacaine liposome injection is redefining the postoperative pain management market, providing advanced, extended-release local anesthesia solutions for surgical settings worldwide. Senior healthcare executives are closely evaluating how this market is adapting amid shifts toward value-based care, regulatory change, and technological advances.

Market Snapshot: Bupivacaine Liposome Injection

The global market for bupivacaine liposome injection is experiencing significant momentum as hospitals, surgery centers, and clinics invest in improved analgesia with sustained release capabilities. Early adoption is demonstrated by leading regions leveraging advanced perioperative care pathways and integration of real-time data tracking, solidifying the product’s role in reducing opioid dependency and supporting accelerated patient discharge. Regulatory shifts and international trade adjustments are further influencing sourcing and procurement strategies in developed and emerging markets alike.

Scope & Segmentation

This comprehensive research covers all critical market dimensions influencing bupivacaine liposome injection adoption:

  • End Use: Ambulatory surgery centers, clinics, hospitals
  • Indication: Postoperative pain management, regional anesthesia
  • Application: Cosmetic, general, orthopedic surgery
  • Distribution Channels: Hospital, online, and retail pharmacy sectors
  • Patient Type: Adult and pediatric patients
  • Product Type: Branded and generic offerings
  • Packaging: Multi-dose vials, prefilled syringes, single-dose vials
  • Regions & Markets: Coverage extends across Americas (select U.S. states, Canada, Mexico, Brazil, Argentina), EMEA (select European, Middle Eastern, and African markets), and Asia-Pacific (including major East, South, and Southeast Asian economies)
  • Leading Competitors: Pacira BioSciences, Apotex, Teva Pharmaceuticals USA, Sandoz, Eton Pharmaceuticals, Mayne Pharma Group

Primary Keyword: Bupivacaine Liposome Injection

Key Takeaways for Decision Makers

  • Single-dose, extended-release bupivacaine formulations are driving new postoperative care standards, contributing to ongoing reduction in opioid reliance and improving patient satisfaction.
  • Digital perioperative platforms paired with sustained-release local anesthetics allow for real-time tracking of pain scores and medication use, supporting protocol adherence and cost controls.
  • Advancements in nanoparticle carrier science have opened opportunities for extended, customizable analgesic effects and innovative combination therapies, targeting faster and more predictable recovery timelines.
  • Regulatory endorsement for multimodal analgesia and updated labeling reflects positive safety profiles and has increased market adoption in both inpatient and outpatient settings.
  • Packaging innovations, such as multi- and single-dose vials and prefilled syringe options, enhance operational flexibility for both high-volume surgery centers and outpatient clinics.
  • Strategic partnerships between pharmaceutical manufacturers and logistics providers, along with digital inventory systems, ensure product stability and reliability from production to point of care.

Tariff Impact on Supply Chain & Pricing

Forthcoming tariff changes in the United States, set for 2025, will affect costs for internationally sourced raw materials such as phospholipids and excipients critical to bupivacaine liposome injection. Manufacturers and procurement teams are adjusting supply chains, including more vertical integration and alternative sourcing, to preserve price competitiveness and secure consistent supply. These developments are compelling closer collaboration between pharmacy, clinical, and finance leadership regarding budget planning and value-driven purchasing models.

Methodology & Data Sources

This report relies on in-depth primary research, including confidential expert interviews, and robust secondary analysis of clinical literature, trial registries, and regulatory databases. Quantitative findings are supported by triangulated data from anonymized procurement and utilization records, delivering credible intelligence and transparency for senior leaders.

Why This Report Matters

  • Actionable insights enable healthcare organizations to align clinical adoption and purchasing with regulatory and economic realities.
  • In-depth segmentation analysis informs resource allocation, market entry, and product positioning strategies across global regions and settings.
  • Forward-looking guidance equips decision makers to anticipate market disruptions, optimize supply channels, and drive effective multimodal pain management protocols.

Conclusion

Bupivacaine liposome injection is positioned as a cornerstone for value-based perioperative care, meeting modern demands for safety, efficiency, and clinical outcomes. The strategies and findings presented here empower senior decision makers to maximize both clinical and commercial impact in a complex, rapidly advancing marketplace.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing demand for liposomal bupivacaine injection in outpatient orthopedic procedures to reduce opioid use
5.2. Expansion of indications for bupivacaine liposome injection in multimodal postoperative pain management protocols
5.3. Emergence of generic competitors challenging the market share of branded liposomal bupivacaine products
5.4. Innovations in ultrasound-guided delivery techniques enhancing efficacy of liposomal bupivacaine injections
5.5. Growing interest in extended-release local anesthetics driving clinical trials for new liposomal bupivacaine formulations
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bupivacaine Liposome Injection Market, by End Use
8.1. Introduction
8.2. Ambulatory Surgery Centers
8.3. Clinics
8.4. Hospitals
9. Bupivacaine Liposome Injection Market, by Indication
9.1. Introduction
9.2. Postoperative Pain Management
9.3. Regional Anesthesia
10. Bupivacaine Liposome Injection Market, by Application
10.1. Introduction
10.2. Cosmetic Surgery
10.3. General Surgery
10.4. Orthopedic Surgery
11. Bupivacaine Liposome Injection Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Bupivacaine Liposome Injection Market, by Patient Type
12.1. Introduction
12.2. Adult
12.3. Pediatric
13. Bupivacaine Liposome Injection Market, by Product Type
13.1. Introduction
13.2. Branded
13.3. Generic
14. Bupivacaine Liposome Injection Market, by Packaging
14.1. Introduction
14.2. Multi Dose Vial
14.3. Prefilled Syringe
14.4. Single Dose Vial
15. Americas Bupivacaine Liposome Injection Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Bupivacaine Liposome Injection Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Bupivacaine Liposome Injection Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Pacira BioSciences, Inc.
18.3.2. Apotex Inc.
18.3.3. Teva Pharmaceuticals USA, Inc.
18.3.4. Sandoz Inc.
18.3.5. Eton Pharmaceuticals, Inc.
18.3.6. Mayne Pharma Group Ltd.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. BUPIVACAINE LIPOSOME INJECTION MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BUPIVACAINE LIPOSOME INJECTION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BUPIVACAINE LIPOSOME INJECTION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. BUPIVACAINE LIPOSOME INJECTION MARKET: RESEARCHAI
FIGURE 30. BUPIVACAINE LIPOSOME INJECTION MARKET: RESEARCHSTATISTICS
FIGURE 31. BUPIVACAINE LIPOSOME INJECTION MARKET: RESEARCHCONTACTS
FIGURE 32. BUPIVACAINE LIPOSOME INJECTION MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BUPIVACAINE LIPOSOME INJECTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY POSTOPERATIVE PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY POSTOPERATIVE PAIN MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY REGIONAL ANESTHESIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY REGIONAL ANESTHESIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY COSMETIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY COSMETIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY MULTI DOSE VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY MULTI DOSE VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY SINGLE DOSE VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY SINGLE DOSE VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 91. CANADA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 92. CANADA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 93. CANADA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 94. CANADA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 95. CANADA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 96. CANADA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 97. CANADA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. CANADA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. CANADA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 100. CANADA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 101. CANADA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 102. CANADA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 103. CANADA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 104. CANADA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 105. MEXICO BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 106. MEXICO BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 107. MEXICO BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 108. MEXICO BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 109. MEXICO BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. MEXICO BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. MEXICO BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. MEXICO BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. MEXICO BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 114. MEXICO BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 115. MEXICO BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 116. MEXICO BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 117. MEXICO BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 118. MEXICO BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 177. GERMANY BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 178. GERMANY BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 179. GERMANY BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 180. GERMANY BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 181. GERMANY BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. GERMANY BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. GERMANY BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. GERMANY BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. GERMANY BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 186. GERMANY BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 187. GERMANY BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 188. GERMANY BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 189. GERMANY BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 190. GERMANY BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 191. FRANCE BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 192. FRANCE BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 193. FRANCE BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 194. FRANCE BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 195. FRANCE BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 196. FRANCE BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 197. FRANCE BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. FRANCE BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. FRANCE BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 200. FRANCE BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 201. FRANCE BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 202. FRANCE BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 203. FRANCE BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 204. FRANCE BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 205. RUSSIA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 206. RUSSIA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 219. ITALY BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 220. ITALY BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 221. ITALY BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 222. ITALY BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 223. ITALY BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. ITALY BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. ITALY BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. ITALY BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. ITALY BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 228. ITALY BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 229. ITALY BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 230. ITALY BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 231. ITALY BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 232. ITALY BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 233. SPAIN BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 234. SPAIN BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 235. SPAIN BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 236. SPAIN BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 237. SPAIN BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. SPAIN BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. SPAIN BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. SPAIN BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. SPAIN BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 242. SPAIN BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 243. SPAIN BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 244. SPAIN BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 245. SPAIN BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 246. SPAIN BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 262. SAUDI ARABIA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 264. SAUDI ARABIA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 276. SOUTH AFRICA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 278. SOUTH AFRICA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 289. DENMARK BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 290. DENMARK BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 291. DENMARK BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 292. DENMARK BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 293. DENMARK BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 294. DENMARK BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 295. DENMARK BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. DENMARK BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. DENMARK BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 298. DENMARK BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 299. DENMARK BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 300. DENMARK BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 301. DENMARK BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2018-2024 (USD MILLION)
TABLE 302. DENMARK BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY PACKAGING, 2025-2030 (USD MILLION)
TABLE 303. NETHERLANDS BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 304. NETHERLANDS BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 305. NETHERLANDS BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 306. NETHERLANDS BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 307. NETHERLANDS BUPIVACAINE LIPOSOME INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 308. NET

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Bupivacaine Liposome Injection market report include:
  • Pacira BioSciences, Inc.
  • Apotex Inc.
  • Teva Pharmaceuticals USA, Inc.
  • Sandoz Inc.
  • Eton Pharmaceuticals, Inc.
  • Mayne Pharma Group Ltd.

Related Topics

Related Reports

Bupivacaine Hydrochloride for Injection Market by Route of Administration (Epidural, Local Infiltration, Peripheral Nerve Block), Concentration (0.25%, 0.5%, 0.75%), Application, End User - Global Forecast 2025-2030 - Product Image

Bupivacaine Hydrochloride for Injection Market by Route of Administration (Epidural, Local Infiltration, Peripheral Nerve Block), Concentration (0.25%, 0.5%, 0.75%), Application, End User - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Postoperative Pain Management Pipeline Analysis Report 2025 - Product Image

Postoperative Pain Management Pipeline Analysis Report 2025

  • Report
  • 200 Pages
  • Global
From
Liposome Injection Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Liposome Injection Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Facet-Joint Injection Global Market Report 2025 - Product Image

Facet-Joint Injection Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Pain Management Information System Market by Delivery Mode (Oral, Parenteral, Transdermal), Product (Local Anesthetics, Non-Opioid Analgesics, Opioids), Indication, Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Pain Management Information System Market by Delivery Mode (Oral, Parenteral, Transdermal), Product (Local Anesthetics, Non-Opioid Analgesics, Opioids), Indication, Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.